Etanidazole
Etanidazole
Etanidazole (pronounced: eh-ta-ni-da-zole) is a synthetic, nitroimidazole-derived radiosensitizer used in the treatment of hypoxic tumor cells.
Etymology
The term "Etanidazole" is derived from the chemical compound class it belongs to, known as nitroimidazoles. The prefix "eta" is a common naming convention in chemistry, often used to denote a specific structural variation within a class of compounds.
Usage
Etanidazole is primarily used as a radiosensitizer in the treatment of hypoxic tumor cells. Hypoxic tumor cells are cancer cells that have adapted to grow in low-oxygen environments and are typically more resistant to radiation therapy. By using Etanidazole, the effectiveness of radiation therapy can be increased, as the drug makes these cells more susceptible to the damaging effects of radiation.
Related Terms
- Radiosensitizer: A drug that makes cancer cells more susceptible to radiation therapy.
- Hypoxic: Referring to an area with low levels of oxygen.
- Radiation therapy: The use of high-energy radiation to kill cancer cells.
- Nitroimidazole: A class of drugs that includes Etanidazole.
See Also
External links
- Medical encyclopedia article on Etanidazole
- Wikipedia's article - Etanidazole
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski